perflutren has been researched along with Acute Coronary Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelmoneim, SS; Bernier, M; Chandrasekaran, K; Dhoble, A; Mankad, SV; Martinez, MW; Mulvagh, SL; Oh, JK; Pellikka, PA | 1 |
| Goldman, JH; Grayburn, PA; Main, ML | 1 |
| Jones, PG; Khalid, A; Khumri, TM; Kusnetzky, LL; Main, ML; Moe, TG | 1 |
3 other study(ies) available for perflutren and Acute Coronary Syndrome
| Article | Year |
|---|---|
Resting qualitative and quantitative myocardial contrast echocardiography to predict cardiac events in patients with acute myocardial infarction and percutaneous revascularization.
Topics: Acute Coronary Syndrome; Aged; Contrast Media; Echocardiography; Female; Fluorocarbons; Follow-Up Studies; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Myocardial Reperfusion; Percutaneous Coronary Intervention; Prognosis; Regression Analysis; Risk Factors; Sensitivity and Specificity | 2015 |
Thinking outside the "box"-the ultrasound contrast controversy.
Topics: Acute Coronary Syndrome; Adult; Aged; Cause of Death; Contraindications; Contrast Media; Drug Labeling; Echocardiography; Female; Fluorocarbons; Heart Failure; Humans; Male; Microbubbles; Myocardial Infarction; Risk Factors; United States; United States Food and Drug Administration; Ventricular Dysfunction, Left | 2007 |
Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent: results in 18,671 consecutive studies.
Topics: Acute Coronary Syndrome; Aged; Contrast Media; Echocardiography; Female; Fluorocarbons; Heart Failure; Hospital Mortality; Humans; Incidence; Inpatients; Male; Middle Aged; Retrospective Studies; Risk Factors; Stroke Volume; Ventricular Dysfunction, Left | 2008 |